For example, the prevalence of declined eGFR in post-menopausal women was the same in FSH quartiles 3 and 4 (both 59%) and the prevalence of CKD was the same in FSH quartiles 2 and 3 (both 1.9%), which were not the expected trends. This evidence concerns the gene BRD2 and chronic kidney disease.